Outpace Bio
Revolutionizing cell therapy with protein design, Outpace reprograms immune cells to make better decisions inside patients, enhancing cell therapy persistence and overcoming biology barriers to cancer treatment. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$576—864m (Dealroom.co estimates Aug 2024.)
Seattle Washington (HQ)
Authorizing premium user...